おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
NeuralStem
company
About
Neuralstem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.
- 1 - 10
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $8M
- Industries
- Biotechnology,Health Care,Neuroscience,Therapeutics
- Founded date
- Jan 1, 1996
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease." Neuralstem's research has allowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$28M
NeuralStem has raised a total of
$28M
in funding over 2 rounds. Their latest funding was raised on
Dec 12, 2016 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 12, 2016 | Post-IPO Equity | $20M | 1 |
|
— | Detail |
| Mar 25, 2013 | Post-IPO Debt | $8M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
NeuralStem is funded by 2 investors.
Tianjin Pharmaceutical Group International Holdings
and Hercules Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Post-IPO Equity |
Hercules Capital
|
— | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
